Post by
europe10 on Sep 29, 2022 12:10pm
last chance?
Tic tac,
DLBCL results should be out soon, or?
"3rd quarter" Hmmmmm
7/8 patients reported ORR before
If IMV can repeat that, or close to those figures, it will be superb results.
That could be the beginning of something big!
If that does not lead to a deal (Merck?) a financing will be imminent
With a reverse split if IMV wants to remain on Nasdaq
IMV might survive even if DLBCL results does not live up to expectations. But shareholders will not get their investment back